Vaccination

Pfizer/BioNTech file for emergency approval for virus vaccine

Pfizer confirmed Friday and that it and partner BioNTech have applied for emergency use authorization for their coronavirus vaccine, becoming the first to do so in the US or Europe as the pandemic rages around the world.

Vaccination

US funding sees Covid-19 antibody trial enter next phase

UK pharmaceuticals group AstraZeneca said on Monday it will advance trials of a Covid-19 treatment to a crucial third stage, after the United States invested $486 million (411 million euros) in its development.

Diseases, Conditions, Syndromes

Testing drive unveiled as virus deaths pass one million

Coronavirus tests that deliver results in 15-30 minutes are to be rolled out across the United States and in scores of poorer countries, as health authorities worldwide try to get a handle on a disease that has now killed ...

Diseases, Conditions, Syndromes

Sanofi, GSK reach virus vaccine deals with US, EU

Pharma giants Sanofi and GSK will receive up to $2.1 billion from the US government for the development of a COVID-19 vaccine, the companies said Friday, as the world scrambles for an answer to the pandemic.

Diseases, Conditions, Syndromes

Sanofi expands US vaccine venture in COVID-19 race

French pharmaceutical giant Sanofi said Tuesday that it would invest $425 million to expand its vaccine development venture with US start-up Translate Bio as they aim to find a COVID-19 vaccine by next year.

page 3 from 5